Sixth Street, a global investment firm, led a $150m Series C round in ConcertAI, a provider of enterprise AI and real-world data. "Our Series C represents another milestone in our emergence as the leader in accelerating biomedical innovations through AI SaaS clinical trial solutions and improved patient outcomes through the generation of real-world evidence for peer-review publications, regulatory decisions, and clinical interpretation," Jeff Elton, ConcertAI CEO.